Latest Articles

Article Type

You have access
Novel Tocolytic Strategy: Modulating Cx43 Activity by S-Nitrosation
Scott D. Barnett, Hazik Asif, Mitchell T. Anderson and Iain L.O. Buxton

Journal of Pharmacology and Experimental Therapeutics December 31, 2020, JPET-AR-2020-000427; DOI: https://doi.org/10.1124/jpet.120.000427
You have access
Opening of intermediate conductance Ca²⁺-activated K⁺ channels in C2C12 skeletal muscle cells increases the myotube diameter via the Akt/mTOR pathway
Yuzo Iseki, Yuko Ono, Chihiro Hibi, Shoko Tanaka, Shunya Takeshita, Yuko Maejima, Junko Kurokawa, Masahiro Murakawa, Kenju Shimomura and Kazuho Sakamoto

Journal of Pharmacology and Experimental Therapeutics December 29, 2020, JPET-AR-2020-000290; DOI: https://doi.org/10.1124/jpet.120.000290
You have access
Identification of a Human Whole Blood-Based Endothelial Cell Impedance Assay for Assessing Clinical TRPV4 Target Engagement Ex Vivo
Xiaoping Xu, Navin Goyal, Melissa H Costell, Theresa Roethke, Christian H James, Kevin S Thorneloe, Jaclyn R Patterson, Patrick Stoy, Krista Goodman, Dennis L Sprecher and David J Behm

Journal of Pharmacology and Experimental Therapeutics December 29, 2020, JPET-AR-2020-000307; DOI: https://doi.org/10.1124/jpet.120.000307
Open Access
Amphetamine-like Neurochemical and Cardiovascular Effects of α-Ethylphenethylamine Analogs Found in Dietary Supplements
Charles W. Schindler, Eric B. Thorndike, John S. Partilla, Kenner C. Rice and Michael H. Baumann

Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 118-126; DOI: https://doi.org/10.1124/jpet.120.000129
You have access
Metoprolol Impairs β1-Adrenergic Receptor-Mediated Vasodilation in Rat Cerebral Arteries: Implications for β-Blocker Therapy
Christopher L. Moore, David S. Henry, Samantha J. McClenahan, Kelly K. Ball, Nancy J. Rusch and Sung W. Rhee

Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 127-135; DOI: https://doi.org/10.1124/jpet.120.000176
You have access
Correction to “Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor”
Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 147; DOI: https://doi.org/10.1124/jpet.119.261065err
You have access
Therapeutic Effect of Neuraminidase-1–Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis
Irina G. Luzina, Erik P. Lillehoj, Virginia Lockatell, Sang W. Hyun, Katerina N. Lugkey, Akihiro Imamura, Hideharu Ishida, Christopher W. Cairo, Sergei P. Atamas and Simeon E. Goldblum

Journal of Pharmacology and Experimental Therapeutics January 2021, 376 (1) 136-146; DOI: https://doi.org/10.1124/jpet.120.000223
You have access
Self-administration of cotinine in Wistar rats: comparisons to nicotine
Zheng-Ming Ding, Yong Gao, Alena Sentir and Xiaoying Tan

Journal of Pharmacology and Experimental Therapeutics December 23, 2020, JPET-AR-2020-000367; DOI: https://doi.org/10.1124/jpet.120.000367
You have access
Manipulating Pharmacodynamic Efficacy with Agonist + Antagonist Mixtures:In Vitro and In Vivo Studies with Opioids and Cannabinoids
Dana E. Selley, Matthew L. Banks, Clare M Diester, Abdul M Jali, Luke P. Legakis, Edna J Santos and S. Stevens Negus

Journal of Pharmacology and Experimental Therapeutics December 22, 2020, JPET-AR-2020-000349; DOI: https://doi.org/10.1124/jpet.120.000349
You have access
RNAi targeting liver Angiopoietin-like protein 3 protects from nephrotic syndrome in a rat model via amelioration of pathologic hypertriglyceridemia
Yitong Zhao, Masaki Goto, Nosratola D Vaziri, Mahyar Khazaeli, Han Liu, Nazli Farahanchi, Elham Khanifar, Ted Farzaneh, Patrick A Haslett, Hamid Moradi and Mangala M Soundarapandian

Journal of Pharmacology and Experimental Therapeutics December 18, 2020, JPET-AR-2020-000257; DOI: https://doi.org/10.1124/jpet.120.000257

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals